课题基金 / 基金详情

Mucosal innate immunity in HIV resistant women

Mucosal innate immunity in HIV resistant women
艾滋病毒耐药女性的粘膜先天免疫
批准号：
342090
负责人：
Roger Michel
金额：
$41.77万
依托单位：
Centre hospitalier de l'Universit de Montral (CHUM)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-03-01 至 2021-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=342090&lang=en
关键词：
Dendritic Cells Female Commercial Sex Workers Genetic Polymorphisms Genital Mucosal Immunity Highly-Exposed Seronegative (Hesn) Hiv/Aids Pathogenesis Interferon

项目摘要

项目成果

Roger Michel的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Most HIV infections are acquired through heterosexual intercourse, and in sub-Saharan Africa, 60% of new HIV infections affect women. Initial exposure to HIV-1 during sexual transmission occurs in the genital tract, however, little is known about HIV-1-sp
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification of Blys/BAFF as a new therapeutic target for limiting immune activation and viral reservoirs during HIV/SIV infection
Modulation of BLyS levels to restore immune efficiency and reduce HIV targets.
Mucosal innate immunity in HIV resistant women